These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 34644235)

  • 1. Bacteria-targeting chitosan/carbon dots nanocomposite with membrane disruptive properties improve eradication rate of
    Arif M; Sharaf M; Samreen ; Dong Q; Wang L; Chi Z; Liu CG
    J Biomater Sci Polym Ed; 2021 Dec; 32(18):2423-2447. PubMed ID: 34644235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of novel pH-sensitive thiolated chitosan/PMLA nanoparticles for amoxicillin delivery to treat Helicobacter pylori.
    Arif M; Dong QJ; Raja MA; Zeenat S; Chi Z; Liu CG
    Mater Sci Eng C Mater Biol Appl; 2018 Feb; 83():17-24. PubMed ID: 29208276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering bioinspired bacteria-adhesive clay nanoparticles with a membrane-disruptive property for the treatment of Helicobacter pylori infection.
    Ping Y; Hu X; Yao Q; Hu Q; Amini S; Miserez A; Tang G
    Nanoscale; 2016 Sep; 8(36):16486-98. PubMed ID: 27605059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Residence Time-Extended Nanoparticles by Magnetic Field Improve the Eradication Efficiency of
    Yang SJ; Huang CH; Yang JC; Wang CH; Shieh MJ
    ACS Appl Mater Interfaces; 2020 Dec; 12(49):54316-54327. PubMed ID: 33236884
    [No Abstract]   [Full Text] [Related]  

  • 5. Construction and optimization of pH-sensitive nanoparticle delivery system containing PLGA and UCCs-2 for targeted treatment of Helicobacter pylori.
    Luo M; Jia YY; Jing ZW; Li C; Zhou SY; Mei QB; Zhang BL
    Colloids Surf B Biointerfaces; 2018 Apr; 164():11-19. PubMed ID: 29367052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucus penetration enhanced lipid polymer nanoparticles improve the eradication rate of Helicobacter pylori biofilm.
    Li P; Chen X; Shen Y; Li H; Zou Y; Yuan G; Hu P; Hu H
    J Control Release; 2019 Apr; 300():52-63. PubMed ID: 30825476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and evaluation of novel pH-sensitive ureido-conjugated chitosan/TPP nanoparticles targeted to Helicobacter pylori.
    Jing ZW; Jia YY; Wan N; Luo M; Huan ML; Kang TB; Zhou SY; Zhang BL
    Biomaterials; 2016 Apr; 84():276-285. PubMed ID: 26851392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibacterial and antibiofilm activity of mannose-modified chitosan/PMLA nanoparticles against multidrug-resistant Helicobacter pylori.
    Arif M; Ahmad R; Sharaf M; Samreen ; Muhammad J; Abdalla M; Eltayb WA; Liu CG
    Int J Biol Macromol; 2022 Dec; 223(Pt A):418-432. PubMed ID: 36356866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Helicobacterpylori effectiveness and targeted delivery performance of amoxicillin-UCCs-2/TPP nanoparticles based on ureido-modified chitosan derivative.
    Jing ZW; Luo M; Jia YY; Li C; Zhou SY; Mei QB; Zhang BL
    Int J Biol Macromol; 2018 Aug; 115():367-374. PubMed ID: 29660462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chitosan-based nanoparticles as delivery-carrier for promising antimicrobial glycolipid biosurfactant to improve the eradication rate of
    Arif M; Sharaf M; Samreen ; Khan S; Chi Z; Liu CG
    J Biomater Sci Polym Ed; 2021 Apr; 32(6):813-832. PubMed ID: 33428545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retention Time Extended by Nanoparticles Improves the Eradication of Highly Antibiotic-Resistant
    Yao CJ; Yang SJ; Huang CH; Chang YT; Wang CH; Shieh MJ; Young TH
    Pharmaceutics; 2022 Oct; 14(10):. PubMed ID: 36297552
    [No Abstract]   [Full Text] [Related]  

  • 12. Smart drug delivery against Helicobacter pylori: pectin-coated, mucoadhesive liposomes with antiadhesive activity and antibiotic cargo.
    Gottesmann M; Goycoolea FM; Steinbacher T; Menogni T; Hensel A
    Appl Microbiol Biotechnol; 2020 Jul; 104(13):5943-5957. PubMed ID: 32399588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stomach specific anti-helicobacter pylori therapy: preparation and evaluation of amoxicillin-loaded chitosan mucoadhesive microspheres.
    Patel JK; Patel MM
    Curr Drug Deliv; 2007 Jan; 4(1):41-50. PubMed ID: 17269916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotics-free nanoparticles eradicate Helicobacter pylori biofilms and intracellular bacteria.
    Zou Y; Chen X; Sun Y; Li P; Xu M; Fang P; Zhang S; Yuan G; Deng X; Hu H
    J Control Release; 2022 Aug; 348():370-385. PubMed ID: 35662575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polysaccharides as Bacterial Antiadhesive Agents and "Smart" Constituents for Improved Drug Delivery Systems Against Helicobacter pylori Infection.
    Menchicchi B; Hensel A; Goycoolea FM
    Curr Pharm Des; 2015; 21(33):4888-906. PubMed ID: 26290206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amoxicillin-docosahexaenoic acid encapsulated chitosan-alginate nanoparticles as a delivery system with enhanced biocidal activities against
    Khoshnood S; Negahdari B; Kaviar VH; Sadeghifard N; Abdullah MA; El-Shazly M; Haddadi MH
    Front Microbiol; 2023; 14():1083330. PubMed ID: 36846798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and evaluation of lipid polymer nanoparticles for eradicating H. pylori biofilm and impairing antibacterial resistance in vitro.
    Cai J; Huang H; Song W; Hu H; Chen J; Zhang L; Li P; Wu R; Wu C
    Int J Pharm; 2015 Nov; 495(2):728-37. PubMed ID: 26417849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticles incorporated in pH-sensitive hydrogels as amoxicillin delivery for eradication of Helicobacter pylori.
    Chang CH; Lin YH; Yeh CL; Chen YC; Chiou SF; Hsu YM; Chen YS; Wang CC
    Biomacromolecules; 2010 Jan; 11(1):133-42. PubMed ID: 19924885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Floating-bioadhesive gastroretentive Caesalpinia pulcherrima-based beads of amoxicillin trihydrate for Helicobacter pylori eradication.
    Thombre NA; Gide PS
    Drug Deliv; 2016; 23(2):405-19. PubMed ID: 24870198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the factors influencing stomach-specific delivery of antibacterial agents for Helicobacter pylori infection.
    Shah S; Qaqish R; Patel V; Amiji M
    J Pharm Pharmacol; 1999 Jun; 51(6):667-72. PubMed ID: 10454042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.